DrugPatentWatch Database Preview
TIGLUTIK KIT Drug Profile
Which patents cover Tiglutik Kit, and when can generic versions of Tiglutik Kit launch?
Tiglutik Kit is a drug marketed by Italfarmaco Spa and is included in one NDA. There is one patent protecting this drug.
This drug has twenty-three patent family members in nineteen countries.
The generic ingredient in TIGLUTIK KIT is riluzole. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the riluzole profile page.
Summary for TIGLUTIK KIT
| International Patents: | 23 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TIGLUTIK KIT at DailyMed |
Medical Subject Heading (MeSH) Categories for TIGLUTIK KIT
US Patents and Regulatory Information for TIGLUTIK KIT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Italfarmaco Spa | TIGLUTIK KIT | riluzole | SUSPENSION;ORAL | 209080-001 | Sep 5, 2018 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for TIGLUTIK KIT
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2012520254 | ➤ Sign Up |
| Portugal | 2405890 | ➤ Sign Up |
| Denmark | 2405890 | ➤ Sign Up |
| Cyprus | 1113825 | ➤ Sign Up |
| Mexico | 2011008922 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
